secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moringa Acquisition Corp (—)
CIK:        0001835416
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001213900-24-016968
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Moringa Acquisition Corp receives Nasdaq delisting notice for failure to complete business combination within 36 months
--------------------------------------------------------------------------------

- Received delisting notice on Feb 20, 2024; trading would be suspended Feb 29 unless hearing requested.
- Non-compliance with Nasdaq IM-5101-2 requiring SPAC business combination within 36 months of IPO.
- Company will request hearing to stay suspension pending completion of proposed combination with Silexion Therapeutics.
- No assurance Nasdaq will grant relief or that business combination will be completed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024016968/0001213900-24-016968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024016968/ea0200685-8k_moringaacq.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-016968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer